These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 29928454)
1. The prognostic value of the systemic inflammatory score in patients with unresectable metastatic colorectal cancer. Shibutani M; Maeda K; Nagahara H; Fukuoka T; Matsutani S; Kimura K; Amano R; Hirakawa K; Ohira M Oncol Lett; 2018 Jul; 16(1):666-672. PubMed ID: 29928454 [TBL] [Abstract][Full Text] [Related]
2. Prognostic value of systemic inflammation score in patients with esophageal cancer. Yoneda A; Ogata R; Ryu S; Yoshino K; Fukui S; Kugiyama T; Kitasato A; Sugiyama N; Takeshita H; Minami S; Kuroki T Ann Med Surg (Lond); 2024 Jul; 86(7):3852-3855. PubMed ID: 38989204 [TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of the lymphocyte-to-monocyte ratio in patients with metastatic colorectal cancer. Shibutani M; Maeda K; Nagahara H; Ohtani H; Sakurai K; Yamazoe S; Kimura K; Toyokawa T; Amano R; Tanaka H; Muguruma K; Hirakawa K World J Gastroenterol; 2015 Sep; 21(34):9966-73. PubMed ID: 26379401 [TBL] [Abstract][Full Text] [Related]
4. Prognostic importance of the preoperative modified systemic inflammation score for patients with gastric cancer. Lin JX; Lin JP; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu R; Zheng CH; Huang CM; Li P Gastric Cancer; 2019 Mar; 22(2):403-412. PubMed ID: 29982861 [TBL] [Abstract][Full Text] [Related]
5. Preoperative systemic inflammation score (SIS) is superior to neutrophil to lymphocyte ratio (NLR) as a predicting indicator in patients with esophageal squamous cell carcinoma. Fu X; Li T; Dai Y; Li J BMC Cancer; 2019 Jul; 19(1):721. PubMed ID: 31331297 [TBL] [Abstract][Full Text] [Related]
6. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients. Song A; Eo W; Lee S World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648 [TBL] [Abstract][Full Text] [Related]
7. Prognostic Impact of the Preoperative Systemic Inflammation Score in Patients With Pancreatic Ductal Adenocarcinoma. Iguchi T; Iseda N; Hirose K; Itoh S; Harada N; Ninomiya M; Sugimachi K; Honboh T; Maeda T; Sadanaga N; Matsuura H Am Surg; 2023 Jun; 89(6):2213-2219. PubMed ID: 35392670 [TBL] [Abstract][Full Text] [Related]
8. Systemic Inflammatory Score predicts Overall Survival in patients with Cervical Cancer. Xu M; Wu Q; Cai L; Sun X; Xie X; Sun P J Cancer; 2021; 12(12):3671-3677. PubMed ID: 33995642 [No Abstract] [Full Text] [Related]
9. Prognostic value of systemic inflammation score in patients with hepatocellular carcinoma after hepatectomy. Shi S; Chen Q; Ye L; Yin D; Li X; Dai Z; He J Oncotarget; 2017 Oct; 8(45):79366-79375. PubMed ID: 29108315 [TBL] [Abstract][Full Text] [Related]
10. Significance of Markers of Systemic Inflammation for Predicting Survival and Chemotherapeutic Outcomes and Monitoring Tumor Progression in Patients with Unresectable Metastatic Colorectal Cancer. Shibutani M; Maeda K; Nagahara H; Ohtani H; Sakurai K; Yamazoe A; Kimura K; Toyokawa T; Amano R; Kubo N; Tanaka H; Muguruma K; Ohira M; Hirakawa K Anticancer Res; 2015 Sep; 35(9):5037-46. PubMed ID: 26254405 [TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of the pre-chemotherapy lymphocyte-to-monocyte ratio in patients with previously untreated metastatic colorectal cancer receiving FOLFOX chemotherapy. Lin GN; Liu PP; Liu DY; Peng JW; Xiao JJ; Xia ZJ Chin J Cancer; 2016 Jan; 35():5. PubMed ID: 26740116 [TBL] [Abstract][Full Text] [Related]
12. Lymphocyte-to-Monocyte Ratio and Prognostic Nutritional Index Predict Poor Prognosis in Patients on Chemotherapy for Unresectable Pancreatic Cancer. Shimizu T; Taniguchi K; Asakuma M; Tomioka A; Inoue Y; Komeda K; Hirokawa F; Uchiyama K Anticancer Res; 2019 Apr; 39(4):2169-2176. PubMed ID: 30952764 [TBL] [Abstract][Full Text] [Related]
13. Systemic inflammation score predicts survival in patients with intrahepatic cholangiocarcinoma undergoing curative resection. Zhang Y; Shi SM; Yang H; Yang LX; Wang Z; Li XD; Yin D; Shi YH; Cao Y; Dai Z; Zhou J; Chen Q J Cancer; 2019; 10(2):494-503. PubMed ID: 30719145 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value of inflammation-based scores in patients receiving radical resection for colorectal cancer. Wang F; He W; Jiang C; Guo G; Ke B; Dai Q; Long J; Xia L BMC Cancer; 2018 Nov; 18(1):1102. PubMed ID: 30419863 [TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of the preoperative lymphocyte-to-monocyte ratio in patients with colorectal cancer. Shibutani M; Maeda K; Nagahara H; Iseki Y; Ikeya T; Hirakawa K Oncol Lett; 2017 Feb; 13(2):1000-1006. PubMed ID: 28356991 [TBL] [Abstract][Full Text] [Related]
16. The prognostic significance of the advanced lung cancer inflammation index in patients with unresectable metastatic colorectal cancer: a retrospective study. Shibutani M; Maeda K; Nagahara H; Fukuoka T; Matsutani S; Kimura K; Amano R; Hirakawa K; Ohira M BMC Cancer; 2019 Mar; 19(1):241. PubMed ID: 30885163 [TBL] [Abstract][Full Text] [Related]
17. Comparison of Preoperative Inflammation-based Prognostic Scores in Patients With Colorectal Cancer. Suzuki Y; Okabayashi K; Hasegawa H; Tsuruta M; Shigeta K; Kondo T; Kitagawa Y Ann Surg; 2018 Mar; 267(3):527-531. PubMed ID: 27984214 [TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of the Perioperative Systemic Inflammation Score for Patients With Curatively Resected Gastric Cancer. Ju M; Aoyama T; Fukuda M; Ishiguro T; Kano K; Kazama K; Sawazaki S; Tamagawa H; Yukawa N; Rino Y Cancer Diagn Progn; 2022; 2(6):627-633. PubMed ID: 36340444 [TBL] [Abstract][Full Text] [Related]
19. The Systemic Inflammation Score is Associated with the Survival of Patients with Prostate Cancer. Xie J; Xiao X; Dong Z; Wang Q J Inflamm Res; 2023; 16():963-975. PubMed ID: 36915616 [TBL] [Abstract][Full Text] [Related]
20. Prognostic Significance of the C-Reactive Protein-to-Albumin Ratio in Patients With Metastatic Colorectal Cancer Treated With Trifluridine/Thymidine Phosphorylase Inhibitor as Later-line Chemotherapy. Shibutani M; Nagahara H; Fukuoka T; Iseki Y; Matsutani S; Wang EN; Maeda K; Hirakawa K; Ohira M Anticancer Res; 2019 Feb; 39(2):1051-1057. PubMed ID: 30711994 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]